Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in pulmonary arterial hypertension and right heart failure
Event:
ESC Congress 2018
Topic:
Pharmacotherapy
Session:
Pulmonary hypertension: progress in management, impact on outcomes
